Emphysema is a type of lung disease that causes shortness of breath. In a person with emphysema, the alveoli are damaged. The alveoli walls and the elastic fibers are damaged and lost. Learn more about Emphysema and Pulmonary Fibrosis: https://bit.ly/1ONmRdG…
Emphysema Treatment – Pulmonary Fibrosis
Pulmonary Fibrosis Symptoms: Nancy’s Story
https://www.youtube.com/watch?v=0mrrh1lcYbY Learn more about PF: https://bit.ly/1lfMsiZ…
Researchers at the University of Miami (UM), led by Assistant Professor Ashutosh Agarwal, are developing functional organs able to mimic real human organs. These laboratory-developed structures, based on chips, could revolutionize approaches to disease treatment by allowing researchers to peer into organs and their related diseases. The research team used an innovative approach…
Learn more about Pulmonary Fibrosis: https://bit.ly/1lfMsiZ…
The Pulmonary Fibrosis Foundation (PFF) recently announced that its PFF Care Center Network has added 19 new sites, almost double its previous number, and now totals 40 centers across 26 U.S. states. The Network, started in 2013, is a group of leading medical centers with specific expertise in the treatment of pulmonary fibrosis (PF), a…
#TBT – Remembering Charlie Boone
Charlie Boone died past Sunday at the age of 88. Boone was the WCCO Radio host who was the voice of mornings in Minnesota for nearly 40 years and one of its stars. “Charlie was one of the greatest talents in the history of radio broadcasting, and…
Types Of Pulmonary Diseases
“Learn what the main classifications of lung diseases are: obstructive, restrictive, ventilation, and perfusion. Discover the classification of common diseases like asthma, emphysema, and pneumonia.” Learn more about Pulmonary Fibrosis: https://bit.ly/1lfMsiZ…
The recently concluded Pulmonary Fibrosis Foundation (PFF)’s third biennial scientific conference, Summit 2015: From Bench to Bedside, achieved a record attendance of over 700 people — from pulmonary fibrosis researchers, academics and healthcare specialists to industry front-runners and PF patients/caregivers — representing 18 countries. Attendees presented research and discussed new treatments in a collaborative setting…
Veracyte, Inc.recently presented four abstracts on current diagnostic challenges related to interstitial lung disease (ILD) and the potential for improved diagnostic procedures using novel genomic-based strategies. The abstracts were given at the Pulmonary Fibrosis Foundation’s PFF Summit 2015: From Bench to Bedside at the JW Marriott Hotel…
A team of researchers report that a mouse’s age influences the ability of its mesenchymal stem cells to repair pulmonary fibrosis-induced damage, a finding with significant implications for stem cell therapies. The study, “Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis,”…
Your PF Community
Recommended Posts
- DNA changes in lungs may influence disease risk in IPF: Study
- Volunteering allows me to be of service to my community
- Pulmonary fibrosis pushed my husband to pivot in his career
- Protein linked to mechanical stress drives pulmonary fibrosis: Study
- I’m living proof of the profound impact of organ donation
